New drug ALT-BB4 put to the test in healthy volunteers
NCT ID NCT05232175
First seen Feb 01, 2026 · Last updated May 23, 2026 · Updated 15 times
Summary
This early-stage study tested the safety and tolerance of a new drug called ALT-BB4 in 290 healthy adults. Researchers monitored for allergic reactions and other side effects after injection. The goal was not to treat any disease, but to gather initial safety data before future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH, SUBJECTIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.